Brain Computer Interface (BCI) Integrated Wearable Hand Robotic Glove System for Upper Limb Stroke Rehabilitation

Sponsor
Tan Tock Seng Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06076928
Collaborator
Nanyang Technological University (Other), Singapore University of Technology & Design (Other), National University of Singapore (Other)
60
1
3
10
6

Study Details

Study Description

Brief Summary

Upper extremity (UE) recovery remains a huge rehabilitation challenge with largely incomplete recovery of the upper limb post stroke. This is due to heavier priorities placed on other stroke competencies such as mobility, activities of daily living training and home integration which results in suboptimal amounts of time spent in upper limb training post stroke.

In this study the investigators plan to pilot brain computer interface (BCI) integrated wearable hand robotic glove (HandyRehab) system for upper limb stroke rehabilitation.

Condition or Disease Intervention/Treatment Phase
  • Device: Brain Computer Interface integrated HandyRehab platform (BCI-HR)
  • Device: HandyRehab (HR)
  • Other: Standard Treatment of Care
N/A

Detailed Description

Robot-aided therapy have shown promising results in rehabilitation recovery in stroke patients while reducing strain and effort for both the therapist and suitable patients.

HandyRehab (HR) is a portable, wearable hand robotic glove used for functional training. The integration of Brain Computer Interface (BCI) platform with HR provides an alternative way of communication or intended movement through end-effectors for stroke and potentially facilitate neuroplasticity, improving motor functions.

This study aims to validate the usability of intensive training with HandyRehab (HR) compared with conventional occupational therapy (CT). Feasibility and safety of the novel BCI-HR will be examined and objective measures of clinical efficacy will be compared across all 3 platforms.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The study design is a prospective, single-centre, single blinded 3-arm randomised controlled trial to compare upper extremity motor and functional outcomes and health related quality of life (HR-QOL) of 3 treatment modalities which are fully clinic-based and supervised by trained occupational therapists (OT). Participants will undergo dose matched training interventions with 1:1 allocation using single-blinded RCT.The study design is a prospective, single-centre, single blinded 3-arm randomised controlled trial to compare upper extremity motor and functional outcomes and health related quality of life (HR-QOL) of 3 treatment modalities which are fully clinic-based and supervised by trained occupational therapists (OT). Participants will undergo dose matched training interventions with 1:1 allocation using single-blinded RCT.
Masking:
Single (Outcomes Assessor)
Masking Description:
Assessors (occupational therapist performing measurements/outcome) not involved in participant training will be blinded to assignments of participants.
Primary Purpose:
Treatment
Official Title:
Brain Computer Interface (BCI) Integrated Wearable Hand Robotic Glove System for Upper Limb Stroke Rehabilitation: A 3-arm Randomized Controlled Trial
Anticipated Study Start Date :
Dec 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2024
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Sham Comparator: Conventional supervised occupational therapy (CT)

CT consists of standard occupational therapy for hand function which includes but not limited to the following treatment (1) passive and active mobilisation; (2) spasticity management; (3) training with use of various modalities/equipment; (4) gross and fine motor training including reach and grasp/release functions, and object manipulation; (5) grasp training: cylindrical, spherical, intrinsic, 2-finger pincer and 3-finger grip.

Other: Standard Treatment of Care
Standard Conventional Occupational Therapy

Active Comparator: HandyRehab (HR) with supervised training by OT

HR training consists of (1) passive and active mobilisation (2) spasticity management (3) gross motor training with HR applied (4) grasp training: cylindrical, spherical, intrinsic, 2-finger pincer and 3-finger grip.

Device: HandyRehab (HR)
A wearable hand robotic glove approved by Health Sciences Authority, class I commercial device

Other: Standard Treatment of Care
Standard Conventional Occupational Therapy

Experimental: HandyRehab integrated with BCI (BCI-HR) with supervised training by OT

BCI-HR training consists of (1) passive and active mobilisation (2) spasticity management (3) gross motor training with BCI-HR applied (4) grasp training: cylindrical, spherical, intrinsic, 2-finger pincer and 3-finger grip.

Device: Brain Computer Interface integrated HandyRehab platform (BCI-HR)
To test the usability, safety and efficacy of an experimental prototype of a wearable hand robotic glove integrated with brain computer interface system being developed and researched.

Other: Standard Treatment of Care
Standard Conventional Occupational Therapy

Outcome Measures

Primary Outcome Measures

  1. Action Research Arm Test (ARAT) Score [Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)]

    Functional and dexterity score in the affected arm evaluated using 19 tests of motor function across 4 subsets; minimum score = 0, maximum score = 57, with higher score indicating better function.

Secondary Outcome Measures

  1. Fugl-Meyer Motor Assessment (FMA) scale [Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)]

    Change in Fugl Meyer Motor Assessment score in the affected arm, minimum: 0, maximum: 66 with higher scores indicating greater levels of mobility function

  2. Grip Strength (kg) [Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)]

    Measured by Digital hand-held Dynamometer (mean of 3 readings) for both hands

  3. Box and Block Test (BBT) [Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)]

    Measures unilateral gross manual dexterity.

  4. Nine Hole Peg Test (NHPT) [Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)]

    Measures finger dexterity in stroke patients.

  5. Self-efficacy outcomes by UPSET (upper limb self-efficacy test) [Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)]

    Questionnaire to measure self-efficacy in various tasks after stroke.

  6. Hr-QOL scales using SS-QOL (Stroke specific Quality of Life scale) [Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)]

    Quality of life scale specific to stroke patients, minimum 49, maximum 245; with higher scores indicating better function.

  7. Patient reported Outcome Measures (PROMs) using subjective scales (Likert 0-5) [Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)]

    Measures patient's opinion on the usability of HR and BCI-HR

  8. Montreal Cognitive Assessment (MOCA) [Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)]

    Screening assessment to determine cognitive impairment.

  9. Rey Auditory Verbal Learning Test (RAVLT) [Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)]

    Cognitive assessment to evaluate verbal learning and memory

  10. Trail Making Test (TMT) [Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)]

    Neuropsychological test assessing visual attention and task switching.

  11. Digit Span [Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)]

    Cognitive Assessment of both forward and backward variants.

  12. Controlled Oral Word Association Test (COWAT) [Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)]

    Neuropsychological measure of verbal fluency.

Other Outcome Measures

  1. Modified Ashworth Scale (MAS) [Weeks 0 (baseline), 6 (end training), 24, 52 (follow-up)]

    Measures the level of spasticity at the elbow and finger flexors of proximal interphalangeal joint regions; scored from "0 to 4" with "4" indicating affected part is more spastic in flexion/extension.

  2. Visual Analogue Scale (self-reported pain score) [Weeks 0 (baseline), 6 (end training), 12, 24, 52 (follow-up)]

    Unidimensional measure of pain intensity; "0" being no pain and "10" being worst pain.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age 21-85 years, males and females

  2. First diagnosis of stroke (ischemic or haemorrhagic), confirmed by neurologist/neurosurgeon/CT/MRI imaging

  3. 16 weeks post stroke

  4. Hemiplegic pattern of post-stroke weakness

  5. MRC ≥ 2/5 motor power and above for shoulder abduction & elbow flexion

  6. MRC 0 to 4/5 motor power and above for finger flexors &/or extensors of thumb, index, middle fingers

  7. Screening Fugl-Meyer wrist hand sub score <18/24

  8. Spasticity MAS <3 for thumb, index, and middle fingers

  9. Able to discriminate thumb and index sensation to pain

  10. Hand sizes within 170-200mm (length) &75-85mm (width), compatible with HandyRehab robotic glove

  11. BCI compatible brain states using a standardised screening protocol

  12. Able to understand simple commands with Mini Mental state examination scores MMSE > 21/30)

  13. Able to give informed consent

  • Subjects who are unable to clear BCI screening 11. will be randomised to either CT or HR groups.
Exclusion Criteria:

Neurological

  • Recurrent stroke

  • Diagnosis of neurodegenerative disease; e.g. Parkinson's' disease, Dementia, ALS

Medical:
  • unstable medical or neurological conditions, life expectancy <6 months, end-organ renal failure on dialysis, severe heart failure, postural hypotension, history of uncontrolled sepsis, epilepsy with seizure within 3 months of informed consent, skin conditions which could potentially be worsened by wearable robot (ulcers, open wounds, eczema, infections etc)
Postural:
  • Unable to tolerate upright posture or sit unaided for < 90min with rest breaks

  • Cognitive/behavioural/visual:

  • Severe dysphasia/aphasia, severe visual neglect/blindness, untreated severe depression, psychiatric illness, unable to understand study requirements

Upper limb:
  • Moderate to severe spasticity (Modified Ashworth scale MAS ≥2)

  • Hand/arm related pain (VAS Pain ≥ 5/10),

  • Presence of finger contractures, reduced functional range of motion, limiting functional wrist/finger movements, active fractures or arthritis with deformities

  • Severe limb ataxia/apraxia

  • Severe post stroke hemi-anaesthesia in affected UE

BCI incompatibility:
  • Motor imagery EEG signals unable to be detected

  • Presence of craniectomy skull defect (affecting BCI cap fit and electrode contact)

  • Concomitant participation in other interventional research trials

  • Resident of nursing home or overseas country which may compromise attendance at research site

  • Pregnant or lactating females will not be allowed to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tan Tock Seng Hospital Singapore Singapore 308433

Sponsors and Collaborators

  • Tan Tock Seng Hospital
  • Nanyang Technological University
  • Singapore University of Technology & Design
  • National University of Singapore

Investigators

  • Principal Investigator: Karen Chua, Tan Tock Seng Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tan Tock Seng Hospital
ClinicalTrials.gov Identifier:
NCT06076928
Other Study ID Numbers:
  • DSRB 2022/00694
First Posted:
Oct 11, 2023
Last Update Posted:
Oct 11, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tan Tock Seng Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 11, 2023